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Abstract
Desmoplastic melanoma commonly occurs on the head and neck in a pure form, but occasionally, it occurs in a mixed tumor with
another type, usually superficial spreading melanoma (SSM), and rarely as a metastasis from a primary SSM. We report here a
primary SSM on the leg of a 32-year-old male which metastasised to lymph nodes, and 10 years later recurred at the primary site
initially with mixed features but evolving to resemble a uniformly desmoplastic, deeply invasive melanoma. This unusual case
has implications for clinical management and is additionally notable for its reversal in behavior, from metastatic to local
infiltrative type, correlating with the change in morphology.
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Desmoplastic melanoma most commonly occurs on the head
and neck as a poorly circumscribed dermal mass and tends to
recur locally rather than metastasise [1]. It usually occurs in
pure form but occasionally is seen as a desmoplastic compo-
nent of a mixed tumor with the other element being a lentigo
malignant melanoma (LMM) or superficial spreading mela-
noma (SSM) type and behavior then relates to the more ag-
gressive component [2]. Very rarely a metastasis from SSM
occurs as a desmoplastic lesion [3, 4]. We describe here a
primary melanoma of clear SSM phenotype which
metastasised to lymph nodes and showed in-transit metasta-
ses, but 10 years later recurred near the scar at the primary site
with mixed conventional and desmoplastic features and then
progressed to resemble a completely desmoplastic, deeply in-
vasive melanoma at the original site. We believe it important
to record this unusual case as it has implications for clinical
management. In addition, we note that the reversal in aggres-
sive behavior from metastatic to local infiltrative type was
correlated with the change in morphology.
Case report
In 2005, a male aged 32 years was referred by his general
practitioner to a plastic surgeon with a newly acquired
pigmented lesion on the left calf suspected to be melanoma.
This was excised and histologically diagnosed as SSM, 1.5-
mm thick, with mitotic count 6/mm2. It was widely excised
and sentinel node biopsy was performed. Two sentinel nodes
from the left groin both contained a parenchymal metastasis
0.2 mm inmaximum dimension. The melanomawas shown to
have a BRAFV600E mutation.
In the same year, 2005, the patient had six clinically
benign moles on the mid- and upper back excised, one
of which was histologically melanoma in situ. In 2008,
three further pigmented lesions were removed from the
left anterior calf, left lateral thigh, and left anterior shin.
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All were confirmed as benign junctional naevi,
completely excised. However, in 2009, 4 years after
diagnosis of the primary SSM, the patient found a nod-
ule in the upper left popliteal fossa. Histology showed
completely excised metastatic melanoma. In 2011,
6 years after diagnosis of the primary SSM, new pig-
mentation was noted adjacent to the original scar, and
on excision was histologically diagnosed as a junctional
naevus with dysplasia without a dermal component
(Figs. 1, 2, 3).
In 2015, 10 years after excision of the primary SSM
on the calf, three subcutaneous nodules were identified
near the original scar. On excision, these were shown to
be recurrent melanoma with an epithelioid component
similar to the original, but merging with a spindle cell
desmop las t i c componen t . The deepe r sp ind l e
desmoplastic component was S100-posit ive but
HMB45-negative, in contrast to the original melanoma
which was HMB45-positive.
In August 2016, a further subcutaneous lesion was identi-
fied on the left calf underlying the previous scar. This was
excised and described histologically as spindle cell recurrent
melanoma. Ten months later in June 2017, and 12 years after
diagnosis of the original primary SSM, another excision of a
further subcutaneous lesion near the original scar showed
merging of atypical spindle cells with scarring suggesting pro-
gression to desmoplastic melanoma. In April 2018, another
nodule excised near the scar showed features of desmoplastic
melanoma extending to the margins of the specimen. A further
excision in May 2018 contained more desmoplastic melano-
ma still showing a BRAFV600E mutation, and this time
appearing completely excised. In September 2020, the patient
was referred to another hospital with intrathoracic lesions ra-
diologically suspected as metastases. A biopsy was not
proposed as the features were so highly consistent with meta-
static melanoma.
Discussion
The histological interest of this case rests on the evolution
over a 10-year period from primary SSM with nodal metasta-
ses to a spindle cell tumor with desmoplasia and without fur-
ther metastasis but recurring locally with features of
desmoplastic melanoma. The earlier metastases of
epithelioid-type melanoma were to a groin node and an in-
transit metastasis in the popliteal fossa. These were complete-
ly excised.
Ten years after the original excision, the tumor re-
curred in the original scar with mixed epithelioid and
spindle cell features and this then recurred again with
spindle/desmoplastic features 13 years after the original
Fig. 1 The superficial part of the presenting melanoma in 2005 on the left
leg showing pagetoid infiltration, characteristic of SSM
Fig. 2 The skin over the excised lesion in 2015 on the left leg, 10 years
later showing the dermal proliferation of spindle cells with desmoplasia
Fig. 3 The skin seen in Fig. 2 shows elongated spindle cells positive with
S100
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presentation. It had the infiltrative pattern of a
desmoplastic melanoma and a further complete excision
was achieved. No perineural invasion or neutropism was
identified. Not only did the histological features change
with time but also the pattern of growth also changed
from metastatic to locally infiltrative, although it still
retained a BRAF mutation which is unusual in
desmoplastic melanoma. Their molecular features typi-
cally include NF1 mutations as well as in CBL,
ERBB2, MAP2K1, and MAP3K1 [5–7]. It appears that
this melanoma underwent metaplastic change to resem-
ble desmoplastic melanoma and acquired the associated
biological characteristics, but it retained the BRAF mu-
tation and eventually has reverted to biological behavior
more typical of SSM.
The rate of mutations is higher than in most other melano-
mas, and the majority are said to be related to ultraviolet radi-
ation mutagenesis [5].Whether this applies to the large minor-
ity of desmoplastic melanomas that arise on infrequently ex-
posed anatomical sites remains to be established, as does the
genetic signature in mixed desmoplastic and other melanoma
types.
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